PipeBio
AcquiredPipeBio is a SaaS bioinformatics platform to develop antibody drugs.
What it does
Pipe|bio is the bioinformatics cloud for antibody / peptide screening & drug development. We enable scientists to analyze and manage massive amounts of DNA sequencing data themselves without the need for bioinformaticians or programmers. The software is highly visual and enables you to overlay and filter information from different sources across your organization; be it assay data, sequence data or other process metadata. Insights from past results can be used to guide new experiments and they get better as you upload more and more data. Team leads get oversight and these capabilities combined empower organizations to find better drugs, faster. We believe that science moves faster when scientists can curate and analyse their own data.
How it has moved
- acquired
Its domain now points at Benchling.
Next to it in Healthcare and bio · Bioinformatics for antibody drug development
- CytodymeTechstars TS 2025
Cytodyme
- Valink TherapeuticsY Combinator W21
Discovering bispecific antibody drug-conjugates (BsADC) against cancer
- Andson BiotechY Combinator W22
Empowering Mass Spec for Biotech and Beyond
- Abalone BioY Combinator W20
We create activating antibodies to treat diseases others can’t.
- EVQLVTechstars TS 2020
EVQLV: Accelerating the speed that healing reaches those in need
- Intrinsic Medicine (fka Lupa Bio)SOSV SOSV IndieBio 09
Developing the next generation of essential, disease-modifying medicines
- Junction BioscienceY Combinator W24
AI Hypothesis Engine for Molecular Discovery
- Magellan Life SciencesSOSV SOSV IndieBio RebelBio 05
Discovering, deciphering, and developing unique plant proteins using synthetic biology